Tekla Capital Management’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $30.5K | Hold |
|
|||||
|
2023
Q1 | $23.2K | Sell |
|
|||||
|
2022
Q4 | $20.3K | Hold |
|
|||||
|
2022
Q3 | $30K | Hold |
|
|||||
|
2022
Q2 | $53K | Hold |
|
|||||
|
2022
Q1 | $88K | Hold |
|
|||||
|
2021
Q4 | $138K | Hold |
|
|||||
|
2021
Q3 | $188K | Hold |
|
|||||
|
2021
Q2 | $475K | Hold |
|
|||||
|
2021
Q1 | $927K | Hold |
|
|||||
|
2020
Q4 | $856K | Hold |
|
|||||
|
2020
Q3 | $899K | Hold |
|
|||||
|
2020
Q2 | $937K | Buy |
|
|||||
|
2020
Q1 | $478K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $244K | Buy |
|